US Stock MarketDetailed Quotes
DRMA Dermata Therapeutics
- 0.3382
- 0.00000.00%
Trading Apr 19 09:30 ET
2.25MMarket Cap-126P/E (TTM)
0.3382High0.3382Low1.04KVolume0.3382Open0.3382Pre Close350.38Turnover0.02%Turnover RatioLossP/E (Static)6.66MShares3.680052wk High0.35P/B2.03MFloat Cap0.232052wk Low--Dividend TTM5.99MShs Float111.2000Historical High--Div YieldTTM0.00%Amplitude0.2320Historical Low0.3380Avg Price1Lot Size
About Dermata Therapeutics Company
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Company Profile
SymbolDRMA
Company NameDermata Therapeutics
Listing DateAug 13, 2021
Issue Price6.99
Founded2014
CEOMr. Gerald T. Proehl
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3525 Del Mar Heights Road,Suite 322
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-800-2543
Websitehttp://www.dermatarx.com
Company Executives
- Name
- Position
- Salary
- Gerald T. Proehl
- Chairman of the Board, President and Chief Executive Officer
- 505.54K
- Dr. Christopher J. Nardo, PhD
- Senior Vice President and Chief Development Officer
- 393.31K
- Kyri K. Van Hoose
- Senior Vice President, Principal Accounting Officer and Chief Financial Officer
- 378.19K
- Dr. Maria Bedoya Toro Munera, PhD
- Senior Vice President, Regulatory Affairs and Quality Assurance
- --
- David F. Hale
- Lead Independent Director
- 73.00K
- Dr. Wendell D. Wierenga,PhD
- Independent Director
- 50.00K
- Mary M. Fisher
- Independent Director
- 47.50K
- Kathleen D. Scott
- Independent Director
- 55.00K
- Dr. Steven J. Mento,PhD
- Independent Director
- 44.00K
- Brittany K. Bradrick
- Independent Director
- 47.50K
- Andrew Seth Sandler, M.D.
- Independent Director
- 49.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
